A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

Trichomoniasis is one of the most common sexually transmitted infections in the world. It is caused by Trichomonas vaginalis, ...

Pixelgen Technologies today unveiled a novel technology for exploring the dynamic protein interactome at the single cell ...

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the release of the NULISAqpcr™ Custom Assay Development Kit, a ...

OB-24-358 intersected 8.36 grams per tonne ("g/t") gold ("Au") over 15.0 metres within a broad mineralized interval with multiple veins, including 56.0 g/t Au over 1.0 metre and 41.1 g/t Au over 1.0 ...

HIGHLIGHTS Geological and geochemical sampling campaigns designed to guide effective targeting for drill programs in Q2 2025 ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation for Acrivon Therapeutics’ ACR-368 OncoSignature assay designed to detect endometrial cancer patients who can ...

Researchers indicate that the Lumipulse p-tau217 assay may reduce over 50% of lumbar punctures performed for diagnosing ...

PLA codes like 0249U are essential building blocks for new diagnostics, as they solidify assay recognition within payers’ billing systems and often represent a significant step in test validation.

The FDA has granted breakthrough device designation to the ACR-368 OncoSignature assay for use in endometrial cancer.

Portable point-of-care blood tests, done by EMS before hospital arrival, need validation but could guide treatment and ...

tuberculosis. This test, the so-called Molecular Bacterial Load Assay (MBLA), represents a novel innovative tool for monitoring TB treatment. The assay measures M. tuberculosis 16S rRNA ...